CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,916,619
- in 9 filings, $5.9M under 10b5-1 plans
Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-08 | Boulding Mark Elliott Exec. VP and CLO | Sale | −1,405 | $45.23 | $64K | 48,374 |
| 2021-07-08 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right To Buy) | −1,000 | $11.23 | $11K | 5,563 |
| 2021-07-08 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right to Buy) | −1,000 | $11.23 | $11K | 4,563 |
| 2021-07-08 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right To Buy) | −1,100 | $18.01 | $20K | 25,150 |
| 2021-07-08 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right to Buy) | −1,500 | $18.01 | $27K | 23,650 |
| 2021-07-08 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right to Buy) | −1,800 | $18.01 | $32K | 21,850 |
| 2021-07-08 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion · Stock Option (Right to Buy) | −1,405 | $18.01 | $25K | 20,445 |
| 2021-06-11 | Smith Mary L. Director | Grant or award | +1,650 | 1,650 | ||
| 2021-06-11 | Smith Mary L. Director | Grant or award | +963 | 2,613 | ||
| 2021-06-11 | Smith Mary L. Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-11 | Smith Mary L. Director | Grant or award · Stock Option (Right to Buy) | +5,834 | 5,834 | ||
| 2021-06-11 | Peltz Stuart Walter Chief Executive Officer | Grant or award | +6,240 | 22,721 | ||
| 2021-06-11 | Peltz Stuart Walter Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +36,400 | 36,400 | ||
| 2021-06-09 | Svoronos Dawn Director | Sale | −365 | $41.89 | $15K | 27,065 |
| 2021-04-20 | Klein Matthew B. Chief Development Officer | Sale | −1,444 | $46.58 | $67K | 17,006 |
| 2021-04-20 | Klein Matthew B. Chief Development Officer | Sale | −197 | $47.92 | $9K | 16,809 |
| 2021-04-19 | Pauwels Eric Chief Business Officer | Sale | −786 | $48.17 | $38K | 35,701 |
| 2021-04-19 | Klein Matthew B. Chief Development Officer | Sale | −859 | $48.17 | $41K | 18,450 |
| 2021-04-13 | Peltz Stuart Walter Chief Executive Officer | Grant or award | +1,400 | 16,481 | ||
| 2021-02-08 | Utter Christine Marie SVP, Finance & CAO | Exercise or conversion | +2,657 | $33.02 | $88K | 19,166 |
Page 52 of 53 · 1,049 trades